We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

How can we help you today?

EN
Contact Us
  • 06-861.png
Medical Device Reg. No. 20262400454 (Guangdong)

Neurofilament Light Chain Protein (NfL) Assay Kit

NfL (neurofilament light chain) is a sensitive biomarker for axonal injury, and its elevated levels are closely linked to neurodegeneration. In AD, the increase in NfL reflects axonal damage and neuronal dysfunction, serving as an important indicator for evaluating disease progression and therapeutic efficacy. By detecting blood NfL levels, it enables the early identification of AD risk, monitoring of disease progression, and assessment of treatment outcomes, thereby providing vital information on neurodegeneration for clinical practice.

Inquire Now

  • Complete Product Line

    Offers a comprehensive product series to fully meet clinical multi-marker diagnostic needs based on the “A+T+N” standard

  • Leading Performance

    Optimized with self-developed core raw materials, sensitivity reaches sub-pg level.

  • High Automation, Rapid Testing

    Integrated with a high-performance fully automated instrument platform, single-tube loading; first report in 20 min.

  • Stable and Fast Results

    Testing throughput up to 200 T/H, intra-batch CV ≤ 8%, inter-batch CV ≤ 15%

  • Economic Advantage

    The overall solution offers significant cost advantages, effectively reducing the operational burden on medical institutions.

image.png